Rezolute, Inc.
RZLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509261
No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +20 vs. previous quarter
- 144
- 13F valueReported value at the end of Q2 2026
- $450.3M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding RZLT, Q2 2026
No superinvestor reported holding RZLT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Rezolute, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 (view filing) | Mar 30 | 1 day | Evans DaronCFO | PPurchase | +10.0K | $2.85 | +$28.5K | +2.5%414.5K after | |
| Dec 17, 2025 (view filing) | Dec 16 | 1 day | Hogenhuis WladimirDirector | PPurchase | +5.65K | $1.69 | +$9.55K | +5.0%119.7K after | |
| Dec 17, 2025 (view filing) | Dec 16 | 1 day | Roberts Brian KennethChief Medical Officer | PPurchase | +28.0K | $1.70 | +$47.6K | +10.0%308.4K after | |
| Dec 15, 2025 (view filing) | Dec 15 | Same day | Evans DaronCFO | PPurchase | +40.0K | $1.77 | +$70.8K | +10.6%415.9K after | |
| Dec 15, 2025 (view filing) | Dec 15 | Same day | Evans DaronCFO | PPurchase | +5.00K | $1.79 | +$8.95K | +250.0%7.00K after | 2 lots |
| Dec 15, 2025 (view filing) | Dec 15 | Same day | Elam Nevan CCEO | PPurchase | +32.0K | $1.59 | +$50.9K | +5.3%641.1K after | |
| Dec 15, 2025 (view filing) | Dec 15 | Same day | Karnawat Sunil RatilalChief Commercial Officer | PPurchase | +12.1K | $1.62 | +$19.6K | +20.4%71.5K after | 2 lots |
| Jun 26, 2025 (view filing) | Jun 25 | 1 day | Roberts Brian KennethChief Medical Officer | PPurchase | +2.50K | $4.38 | +$10.9K | +19.2%15.5K after | |
| Jun 24, 2025 (view filing) | Jun 24 | Same day | Evans DaronCFO | PPurchase | +5.00K | $4.05 | +$20.3K | +1.9%268.9K after | |
| Jun 23, 2025 (view filing) | Jun 13 | 10 daysLate | Kim Young-JinDirector | PPurchase | +1.23M | $3.25 | +$4.00M | +17.1%8.42M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Rezolute, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 12,990,659 | $67.6M | 0.10% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 9,445,039 | $49.1M | 0.43% | +265,039+2.9% | Added |
| BlackRock, Inc. | 7,718,291 | $40.1M | 0.00% | +1,404,788+22.3% | Added |
| Opaleye Management Inc. | 6,300,000 | $32.8M | 2.97% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 4,662,039 | $24.2M | 0.04% | −386,382−7.7% | Reduced |
| Vanguard Capital Management LLC | 3,835,827 | $19.9M | 0.00% | +313,747+8.9% | Added |
| Siren, L.L.C. | 3,328,287 | $17.3M | 0.35% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 2,561,654 | $13.3M | 0.05% | +2,341,247+1,062.2% | Added |
| Jennison Associates LLC | 2,459,308 | $12.8M | 0.01% | −979,573−28.5% | Reduced |
| Geode Capital Management, LLC | 2,170,154 | $11.3M | 0.00% | +205,795+10.5% | Added |